Transcranial magnetic stimulation effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis

被引:14
|
作者
Yan, Yixin [1 ]
Tian, Minjie [1 ]
Wang, Tong [1 ]
Wang, Xixi [1 ]
Wang, Yingying [1 ]
Shi, Jingping [1 ]
机构
[1] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Neurol, Nanjing, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
transcranial magnetic stimulation; Alzheimer's disease; mild cognitive impairment; cognition; meta-analysis; cerebellum; NONINVASIVE BRAIN-STIMULATION; DOUBLE-BLIND; RTMS; INTERVENTION; EXCITABILITY; DEMENTIA; SPEECH; APATHY; TMS;
D O I
10.3389/fneur.2023.1209205
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionTranscranial magnetic stimulation (TMS) is a non-invasive intervention that holds promise for improving cognitive function in individuals with Alzheimer's disease (AD). However, the effectiveness of this therapy and the optimal TMS parameters has not reached a consensus. The purpose of the meta-analysis was to systematically discern the effectiveness of different components of TMS protocols on cognitive improvement in patients with mild cognitive impairment (MCI) and AD.MethodsThe meta-analysis was preregistered on Prospero (registration number: CRD42022345482). PubMed, Web of Science, Science Direct, and Cochrane Library databases were used to search, screen and identify eligible studies with the following keywords: Transcranial Magnetic Stimulation OR TMS OR theta burst stimulation AND Alzheimer OR Alzheimers OR Alzheimer's OR mild cognitive impairment OR MCI. Randomized controlled trials (RCTs) of participants with accepted standardized diagnostic criteria were searched by two authors independently. The risk of bias was assessed using an adapted Cochrane Risk of Bias tool. Standardized mean difference (SMD) and 95% confidence interval (CI) were calculated using the random-effects models. Subgroup analyses were performed to investigate the influential factors.ResultsA total of 21 studies and 25 trials were included in this meta-analysis. The findings revealed a significant overall cognition improvement of real stimulation compared with sham stimulation (short-term effects: SMD, 0.91; 95% CI 0.44-1.38; P < 0.01; long-lasting effects: SMD, 0.91; 95% CI 0.27-1.55; P < 0.01). Subgroup analysis demonstrated that stimulation of the left dorsolateral prefrontal cortex and bilateral cerebellums, as well as moderate frequency stimulation (5 Hz and 10 Hz) on mild and moderate cognitive impairment patients, were more effective than other TMS protocols. However, the additional application of cognitive training showed no significant improvement.ConclusionCognitive improvement effect of TMS was demonstrated in MCI and AD patients in both short-term assessment and long-lasting outcomes, and the efficiency of TMS is affected by the stimulation frequency, stimulation site, and participant characteristics. Further RCTs are needed to validate the findings of our subgroup analysis.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Risk Factors of Rapid Cognitive Decline in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
    Song, Ya-Nan
    Wang, Ping
    Xu, Wei
    Li, Jie-Qiong
    Cao, Xi-Peng
    Yu, Jin-Tai
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 66 (02) : 497 - 515
  • [22] Efficacy of Vitamins B Supplementation on Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Li, Meng-Meng
    Yu, Jin-Tai
    Wang, Hui-Fu
    Jiang, Teng
    Wang, Jun
    Meng, Xiang-Fei
    Tan, Chen-Chen
    Wang, Chong
    Tan, Lan
    CURRENT ALZHEIMER RESEARCH, 2014, 11 (09) : 844 - 852
  • [23] Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer's disease: a meta-analysis of randomized controlled trials
    Wang, Xin
    Mao, Zhiqi
    Ling, Zhipei
    Yu, Xinguang
    JOURNAL OF NEUROLOGY, 2020, 267 (03) : 791 - 801
  • [24] Repetitive transcranial magnetic stimulation impacts the executive function of patients with vascular cognitive impairment: a systematic review and meta-analysis
    Wang, Xu
    Ding, Qixin
    Li, Yuefang
    Li, Tianshu
    Li, Yakun
    Yin, Jialin
    Zhuang, Weisheng
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [25] Exploring the potential of combining transcranial magnetic stimulation and electroencephalography to investigate mild cognitive impairment and Alzheimer's disease: a systematic review
    Hall, J. D.
    Green, Jacob M.
    Chen, Yu-Chin A.
    Liu, Yilin
    Zhang, Hangbin
    Sundman, Mark H.
    Chou, Ying-hui
    GEROSCIENCE, 2024, 46 (04) : 3659 - 3693
  • [26] Cerebral blood flow in mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
    Zhang, Heng
    Wang, Yan
    Lyu, Diyang
    Li, Yan
    Li, Wenwen
    Wang, Qi
    Qin, Qi
    Wang, Xuechu
    Gong, Min
    Jiao, Haishan
    Liu, Wenying
    Jia, Jianping
    AGEING RESEARCH REVIEWS, 2021, 71
  • [27] Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis
    Ge, Yi-Jun
    Xu, Wei
    Ou, Ya-Nan
    Qu, Yi
    Ma, Ya-Hui
    Huang, Yu-Yuan
    Shen, Xue-Ning
    Chen, Shi-Dong
    Tan, Lan
    Zhao, Qian-Hua
    Yu, Jin-Tai
    AGEING RESEARCH REVIEWS, 2021, 69
  • [28] Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Yang, Guoyan
    Wang, Yuyi
    Sun, Jin
    Zhang, Kang
    Liu, Jianping
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (05) : 520 - 528
  • [29] A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment
    Hird, Megan A.
    Egeto, Peter
    Fischer, Corinne E.
    Naglie, Gary
    Schweizer, Tom A.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (02) : 713 - 729
  • [30] Magnetic Resonance Spectroscopy in Mild Cognitive Impairment and Alzheimer's Disease: Systematic Review and Meta-Analysis
    Song, Tao
    Song, Xiaopeng
    Zhu, Chenyawen
    Du, Fei
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S154 - S154